The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Автори: | , , , , , , |
|---|---|
| Інші автори: | |
| Формат: | Conference item |
| Мова: | English |
| Опубліковано: |
Elsevier
2020
|
| Резюме: |
|---|